Bio-Rad Laboratories

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Bio-Rad Laboratories, Inc.
Traded asNYSEBIO (Class A)
S&P 400 Component
IndustryMedical laboratories,
life science research
FoundersDavid and Alice Schwartz
Area served
Key people
Norman Schwartz (President & CEO)

Giovanni Magni (Chief Strategy Officer)
Christine Tsingos (CFO)
Michael Crowley (EVP Global Commercial Operations)
Annette Tumolo (President, Life Science Group)

John Hertia (President, Clinical Diagnostics Group)
RevenueIncreaseUS$2.2 billion (FY 2018)[1]
DecreaseUS$28.1 million (FY 2016)[1]
Number of employees
8,260 (2018) [1]

Bio-Rad Laboratories, Inc. is a manufacturer of products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.

Business segments[edit]

Bio-Rad’s life science products primarily include instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. These products are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.[2]

Bio-Rad’s diagnostic products and systems use a range of technologies and provide clinical information in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets. These products are used to support the diagnosis, monitoring, and treatment of diseases and other medical conditions.


Bio-Rad Laboratories is based in Hercules, California, located along the Bay.

Bio-Rad Laboratories was founded in 1952 by David Schwartz and his wife Alice, both recent graduates of the University of California, Berkeley.

Bio-Rad expanded into the field of analytical and measuring instrument systems through internal research and development efforts and acquisitions in the late 1970s and 1980s. In 1999, Bio-Rad purchased Pasteur Sanofi Diagnostics. This strengthened the company’s position in the HIV and infectious disease diagnostic product market. In 2000, and 2004, Bio-Rad divested its semiconductor, optoelectronic metrology, and confocal microscopy product lines. In late 2007, Bio-Rad acquired Switzerland-based DiaMed Holding AG, enhancing Bio-Rad’s position in the immunohematology market. In January 2013, Bio-Rad purchased AbD Serotec, a division of MorphoSys AG.[3] This added Serotec’s more than 15,000 antibodies, kits, and accessories to Bio-Rad’s portfolio of research and clinical diagnostic products.[4]

In 2011, Bio-Rad acquired a new technology droplet digital PCR, which extended the company's reach in the area of DNA amplification. Droplet digital PCR allows scientists to distinguish rare sequences in tumors and precisely measure copy number variation.[5] Today the company has direct distribution channels in over 35 countries outside the United States through subsidiaries whose focus is sales, customer service and product distribution. In some locations outside and inside these 35 countries, sales efforts are supplemented by distributors and agents.[6]

Vickers Instruments[edit]

In 1989 Bio-Rad purchased from the British engineering firm Vickers (1828 - 1999) this instrument maker, apart from their defense products which were sold to British Aerospace. This company had been known until 1963 as Cooke, Troughton & Simms and incorporated T. Cooke & Sons a York-based instrument maker founded in 1837 by the self-taught schoolmaster Thomas Cooke and the London instrument-maker Troughton & Simms founded in 1828 by Edward Troughton who began his apprenticeship in 1773.


Bioradiations is an online magazine created by Bio-Rad that offers researchers case studies, whitepapers, tips, techniques, and topics related to Bio-Rad products and services. Bioradiations began as a print magazine that was launched in 1965[7] and was in continuous publication until 2011. Content of the publication includes new product information, technical and application notes describing experiments performed using Bio-Rad products as well as interviews with life science researchers. The site offers interactive content including product demonstrations in the form of system tours, videos, podcasts etc.

See also[edit]


  1. ^ a b c "Bio-Rad Laboratories, Form 10-K, Annual Report, Filing Date Feb 23, 2017" (PDF). Retrieved Feb 23, 2017.
  2. ^ Bio-Rad Annual Report 2016 |
  3. ^ Mark, Barry. "Revenue Update on Bio-Rad Laboratories, Inc". Markets Bureau. Archived from the original on 2 April 2015. Retrieved 4 March 2015.
  4. ^ "Bio-Rad Acquires AbD Serotec from MorphoSys". Genetic Engineering & Biotechnology News. 17 December 2012.
  5. ^ Bio-Rad Annual Report 2011
  6. ^ Bio-Rad Annual Report 2016
  7. ^ BioCompare

External links[edit]

Coordinates: 38°1′23.52″N 122°16′40.35″W / 38.0232000°N 122.2778750°W / 38.0232000; -122.2778750